Blood Activity Measurement
Blood Activity Measurement - Related Videos
11:29
Measuring Granulocyte and Monocyte Phagocytosis and Oxidative Burst Activity in Human Blood
0 Views •
Cited by 5 •
2016
The purpose of this manuscript is to present a method for measuring monocyte and granulocyte phagocytosis and oxidative burst activity in human blood samples.
03:58
Purification and Activation of Platelets from Murine Whole Blood
0 Views •
2025
In this video, we describe a protocol for purifying platelets from murine whole blood and their subsequent activation with the platelet agonist thrombin. When analyzed with flow cytometry, the purified resting platelets are characterized based on the expression of their cell-surface marker CD41, whereas purified activated platelets co-express both the surface markers CD41 and CD62P.
09:31
Noninvasive Blood Pressure Measurement Techniques
0 Views •
2023
Source: Hamna J. Qureshi and Craig J. Goergen, Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana Here we will highlight the key similarities and differences of noninvasive blood pressure measurement techniques between humans and rodents and examine the engineering principles that govern blood pressure. The principles that govern current cuff technology to acquire systolic and diastolic pressures will also be discussed. Commercially available cuffs that connect...
09:30
Measurement of Larval Activity in the Drosophila Activity Monitor
0 Views •
Cited by 10 •
2015
This report describes a method for measuring Drosophila larval activity using the TriKinetics Drosophila Activity Monitor. The device employs infrared beams to detect movements of up to 16 individual animals. Data can be analyzed to represent motion parameters including rates and the positions of the animals within the assay chambers.
04:25
Endotoxin Activity Assay: A Chemiluminescence-Based Bioassay for Investigating Endotoxin Activity in Blood Sample
0 Views •
2025
This video demonstrates a rapid bioassay for investigating endotoxin activity in a whole blood sample via a chemiluminescence-based method. This assay is a rapid and sensitive biomarker test for early-stage diagnosis of endotoxin-mediated sepsis.
FAQs
The arterial input function represents the tracer concentration available to tissues through the blood over time. Blood activity measurements provide the time-dependent data needed to compare circulating tracer with tissue signals during quantitative modeling. This relationship helps estimate tissue uptake rather than relying only on image intensity, making the blood measurements central to interpreting distribution in PET or SPECT.
Changes in activity concentration across timed samples show how rapidly the tracer leaves or remains in circulation. A declining curve can reflect clearance from blood, while its overall time pattern describes the tracer’s changing availability for tissue delivery. These measurements support pharmacokinetic models that analyze distribution and help relate circulating activity to subsequent tissue uptake.
Accurate results depend on the timing of each sample, consistent sample handling, and proper calibration of the radiation detector. Errors in collection time can distort the activity curve, while handling differences can affect measured radioactivity. Detector calibration establishes the relationship between recorded radiation and activity concentration, so all three factors influence the reliability of quantitative interpretation.
Measured blood radioactivity may include the original tracer and radioactive metabolites, which can have different distribution behavior. Correcting for metabolites helps the blood curve better represent the tracer relevant to the intended pharmacokinetic analysis. Without this consideration, estimates of tissue uptake or other model-derived quantities may reflect compounds that do not follow the same biological pathway.
The workflow begins after the radiopharmaceutical enters circulation, followed by collection of blood samples at defined times. Each sample is analyzed with a calibrated radiation detector, and the measurements are organized as activity concentration over time. The resulting curve can then be used for modeling, provided that timing, handling, calibration, and metabolite corrections are appropriately addressed.
The time course from blood samples supplies an input describing tracer availability in circulation. Pharmacokinetic models use this input alongside tissue measurements to evaluate how tracer reaches and accumulates in tissues. In quantitative PET or SPECT research, the resulting analysis can support estimates of tissue uptake and distinguish circulating behavior from tissue-specific activity.
They are useful when researchers need quantitative information about how a radiopharmaceutical behaves after entering the bloodstream. Blood activity data can support estimates of tissue uptake by providing the circulating reference for image-based studies. The same time-dependent measurements also contribute to evaluating radiation exposure, because exposure depends on the tracer’s activity and distribution over time.